Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Severe lameness 'common' in working donkeys
donkey
More than 42 million horses and 95 per cent of the world's donkeys are found in developing countries.

Research findings hope to improve the lives of millions of working equids

New research has found a high incidence of severe lameness, pain and abnormalities of the spine, foot, joint and tendons in working donkeys. It has also underlined the importance of non-steroidal anti-inflammatory drugs (NSAIDS) in dealing with pain-related behaviour.

Dr Becky Way, from the University of Bristol, led three studies to improve understanding of the welfare issues facing working equids.

More than 42 million horses and 95 per cent of the world's donkeys are found in developing countries.

Dr Way explained: "Working horses and donkeys support the livelihoods of some of the world’s poorest people.  However, these animals are often overburdened and used for long hours in harsh conditions.

“We hope our research will make a difference to the lives of these animals and our work will advise owners and vets on how to better look after their animals.”

Researchers aimed to determine the severity of lameness in all working donkeys examined, as well as the clinical signs and affected bone and muscle structures. They believe their findings have paved the way for future studies to identify the risk factors for lameness and to create suitable interventions.

Another paper explores pain-related behaviour in donkeys, to help owners and vets to recognise and manage pain. Findings suggest working donkeys were more active and alert after receiving the NSAID meloxicam.

The research team also found a high incidence of multilimb lameness in working draught horses. They say the link with pain was of serious concern. It is hoped the findings will help identify risk factors and put treatment in place to reduce the frequency of lameness in working equids.

Recently, the International Colloquium on Working Equids was held to address the welfare issues facing 100 million working horses, donkeys and mules. Wider access to research was recommended to encourage greater collaboration globally.

Melissa Upjohn, research co-ordinator at animal welfare organisation, the Brooke, which funded the studies, said: "More research into the problems affecting working horses, donkeys and mules is vitally needed in order to improve the welfare of the animals that support the livelihoods of millions of people across the world."

All three research papers have been published online in the Equine Veterinary Journal:
The range and prevalence of clinical signs and conformation associated with lameness in working draught donkeys in Pakistan

Identifying behavioural differences in working donkeys in response to analgesic administration

The range and prevalence of pathological abnormalities associated with lameness in working horses from developing countries

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.